158 related articles for article (PubMed ID: 37648653)
21. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
22. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study.
Manfredini M; Giuliani AL; Ruina G; Gafà R; Bosi C; Zoppas E; Di Virgilio F; Bettoli V
Dermatology; 2021; 237(1):111-118. PubMed ID: 31454821
[TBL] [Abstract][Full Text] [Related]
23. Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
[TBL] [Abstract][Full Text] [Related]
24. Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs.
Goliwas KF; Kashyap MP; Khan J; Sinha R; Weng Z; Oak ASW; Jin L; Atigadda V; Lee MB; Elmets CA; Mukhtar MS; Raman C; Deshane JS; Athar M
Inflammation; 2022 Jun; 45(3):1388-1401. PubMed ID: 35301634
[TBL] [Abstract][Full Text] [Related]
25. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
[TBL] [Abstract][Full Text] [Related]
26. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
Wolk K; Brembach TC; Šimaitė D; Bartnik E; Cucinotta S; Pokrywka A; Irmer ML; Triebus J; Witte-Händel E; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Sabat R
Br J Dermatol; 2021 Jul; 185(1):164-176. PubMed ID: 33400270
[TBL] [Abstract][Full Text] [Related]
27. Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea.
Cho M; Woo YR; Cho SH; Lee JD; Kim HS
Acta Derm Venereol; 2023 Dec; 103():adv18392. PubMed ID: 38078688
[TBL] [Abstract][Full Text] [Related]
28. Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
Petrasca A; Hambly R; Molloy O; Kearns S; Moran B; Smith CM; Hughes R; O'Donnell M; Zaborowski A; Winter D; Fletcher JM; Kirby B; Malara A
PLoS One; 2023; 18(2):e0281688. PubMed ID: 36780439
[TBL] [Abstract][Full Text] [Related]
29. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
Hessam S; Sand M; Skrygan M; Bechara FG
Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
[TBL] [Abstract][Full Text] [Related]
30. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
31. Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.
Giuffrida R; Cannavò SP; Coppola M; Guarneri C
Curr Pharm Biotechnol; 2021; 22(1):59-72. PubMed ID: 32368973
[TBL] [Abstract][Full Text] [Related]
32. Metformin for the treatment of hidradenitis suppurativa: a little help along the way.
Verdolini R; Clayton N; Smith A; Alwash N; Mannello B
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1101-8. PubMed ID: 22882365
[TBL] [Abstract][Full Text] [Related]
33. Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.
Moussa C; Wadowski L; Price H; Mirea L; O'Haver J
J Drugs Dermatol; 2020 Dec; 19(12):1231-1234. PubMed ID: 33346525
[TBL] [Abstract][Full Text] [Related]
34. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
[TBL] [Abstract][Full Text] [Related]
36. Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
Masson R; Shih T; Jeong C; Shi VY; Hsiao JL
J Drugs Dermatol; 2023 Aug; 22(8):785-794. PubMed ID: 37556513
[TBL] [Abstract][Full Text] [Related]
37. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa.
Grand D; Navrazhina K; Frew JW
Exp Dermatol; 2020 Jan; 29(1):86-92. PubMed ID: 31688984
[TBL] [Abstract][Full Text] [Related]
38. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
[TBL] [Abstract][Full Text] [Related]
39. Emerging drugs for the treatment of hidradenitis suppurativa.
Folkes AS; Hawatmeh FZ; Wong A; Kerdel FA
Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
[TBL] [Abstract][Full Text] [Related]
40. The NLRP3 Inflammasome Gene Is Overexpressed in Hidradenitis Suppurativa Lesions: A Preliminary Study on the Role of Pyroptosis in Disease Pathogenesis.
Krajewski PK; Szukała W; Szepietowski JC
Curr Issues Mol Biol; 2024 Mar; 46(3):2544-2552. PubMed ID: 38534777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
